PI
VNDA icon

Putnam Investments’s Vanda Pharmaceuticals VNDA Stock Holding History

Putnam Investments’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-38,314
Closed -$283K – 1216
2022
Q4 		$283K Sell
38,314
-21
-0.1% -$205 ﹤0.01% 1078
2022
Q3 		$379K Sell
38,335
-695
-2% -$7.34K ﹤0.01% 1002
2022
Q2 		$425K Sell
39,030
-482
-1% -$4.99K ﹤0.01% 978
2022
Q1 		$447K Sell
39,512
-2,955
-7% -$38.8K ﹤0.01% 1042
2021
Q4 		$667K Buy
+42,467
New +$740K ﹤0.01% 908

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Putnam Investments's VNDA Position: Q1 2023 in Review

Putnam Investments sold out of Vanda Pharmaceuticals (VNDA) in Q1 2023, closing a stake of 38,314 shares — an estimated $283K sold.

Putnam Investments first reported a position in VNDA in Q4 2021 and held it in 5 quarters. The position peaked at $667K in Q4 2021. 177 funds tracked by Wall St. Rank hold VNDA as of Q1 2023.

  • Putnam Investments reported no remaining Vanda Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Putnam Investments sold 38,314 Vanda Pharmaceuticals shares in Q1 2023, an estimated $283K.
  • Putnam Investments first reported a position in Vanda Pharmaceuticals in Q4 2021 and held it in 5 quarters.
  • Putnam Investments's Vanda Pharmaceuticals position peaked at $667K in Q4 2021.
  • 177 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2023.

Based on Putnam Investments's 13F filing for Q1 2023, filed 22 May 2023.